Aravinda Nanjundappa

LDL-C vs Lp(a): What We Know, the “Zero-LDL” Hypothesis, and Where We Stand in the PCSK9 Era

Despite significant breakthroughs in preventative medicine, atherosclerotic cardiovascular disease (ASCVD) is still the primary cause of morbidity and death worldwide. In this context, 2 apoB-containing particles-LDL and lipoprotein(a) [Lp(a)] have emerged as important but mechan...